Log In
Print
BCIQ
Print
Print this Print this
 

VX-661

  Manage Alerts
Collapse Summary General Information
Company Vertex Pharmaceuticals Inc.
DescriptionSmall molecule cystic fibrosis transmembrane conductance regulator (CFTR) corrector
Molecular Target Cystic fibrosis transmembrane conductance regulator (CFTR)
Mechanism of Action 
Latest Stage of DevelopmentPhase II
IndicationCystic fibrosis (CF)
Partner

Cystic Fibrosis Foundation
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today